Gene therapy for Friedreich ataxia: Too much, too little, or just right?

Simple item page
dc.contributor.authorPayne, R. Mark
dc.contributor.departmentPediatrics, School of Medicineen_US
dc.date.accessioned2023-05-18T12:46:53Z
dc.date.available2023-05-18T12:46:53Z
dc.date.issued2022-03-04
dc.eprint.versionFinal published versionen_US
dc.identifier.citationPayne RM. Gene therapy for Friedreich ataxia: Too much, too little, or just right?. Mol Ther Methods Clin Dev. 2022;25:1-2. Published 2022 Mar 4. doi:10.1016/j.omtm.2022.02.008en_US
dc.identifier.urihttps://hdl.handle.net/1805/33096
dc.language.isoen_USen_US
dc.publisherElsevieren_US
dc.relation.isversionof10.1016/j.omtm.2022.02.008en_US
dc.relation.journalMolecular Therapy: Methods & Clinical Developmenten_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourcePMCen_US
dc.subjectFriedreich ataxiaen_US
dc.subjectMitochondriaen_US
dc.subjectMonogenetic diseasesen_US
dc.subjectViral gene therapiesen_US
dc.titleGene therapy for Friedreich ataxia: Too much, too little, or just right?en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
main.pdf
Size:
190.86 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Access Policy Articles
Department of Pediatrics Works